Latest news
{{'Tue, 24 Feb 2026 08:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
Read more
{{'Mon, 09 Feb 2026 07:00:00 -0500' | dateFormatUsFilter}}
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
Read more
{{'Fri, 06 Feb 2026 09:08:00 -0500' | dateFormatUsFilter}}
Novo Nordisk takes the field at the big game, putting Wegovy® pill in consumers' hands
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.